EXP039
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for EXP039, covering 2021-05-13 to 2021-05-13. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Crossover Study to Assess EXP039 for Myopia or Hyperopia [Phase 1, Phase 2]